Perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation: a case report and literature review
10.12206/j.issn.1006-0111.202103074
- VernacularTitle:1例冠状动脉支架植入术后患者行髋关节翻修术的围术期抗栓治疗并文献复习
- Author:
Ying LI
1
;
Ailin CAO
2
;
Leilei BAO
2
;
Zhankun WANG
3
;
Jiao QIAN
2
Author Information
1. Department of Pharmacy, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China;Department of Pharmacy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China.
2. Department of Pharmacy, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
3. Department of Pharmacy, Baoding Second Central Hospital, Baoding 072750, China.
- Keywords:
coronary stent implantation;
revision total hip arthroplasty;
perioperative period;
antithrombotic therapy
- From:
Journal of Pharmaceutical Practice
2022;40(4):372-373
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the strategies of perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation. Methods The antithrombotic therapy in one patient undergoing revision total hip arthroplasty after coronary stent implantation was analyzed with the review of related literatures. Results The patient developed non-ST segment elevated myocardial infarction due to the stop of aspirin three days before operation and no low molecular weight heparin was used. The antithrombotic treatment and prevention of venous thromboembolism were analyzed. Conclusion Antithrombotic therapy should be selected reasonably in patients undergoing revision total hip arthroplasty after coronary stent implantation.
